Lobbying activity

Q4

CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q4

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q4

ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income

Health Issues

View → Q4

DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy

View → Q4

E3 STRATEGIC CONSULTING GROUP for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION

4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $50,000.00 income

Pharmacy

View → Q4

MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q4

MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q4

MARSHALL & POPP, LLC for PFIZER, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q4

MARSHALL & POPP, LLC for GENENTECH, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q4

MARSHALL & POPP, LLC for AMGEN USA INC.

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q4

PUBLIC CITIZEN for PUBLIC CITIZEN

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Banking, Civil Rights/Civil Liberties, Computer Industry, Consumer Issues/Safety/Products

View → Q4

THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income

Health Issues

View → Q4

ELITE STRATEGIC SERVICES for CONSERVATIVES FOR PROPERTY RIGHTS

4th Quarter (Oct 1 - Dec 31) 2025 · South Carolina · House · Senate · $100,000.00 income

Copyright/Patent/Trademark, Health Issues, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code

View → Q4

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income

Medicare/Medicaid, Pharmacy

View → Q4

HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY

4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate

Health Issues

View → Q4

AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Health Issues

View → 4T

HORIZON GOVERNMENT AFFAIRS for PHRMA

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income

Health Issues

View → 3A

LUNDBECK LLC for LUNDBECK LLC

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Trade (domestic/foreign), Health Issues, Medicare/Medicaid

View → Q3

YC CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · $30,000.00 income

Health Issues, Trade (domestic/foreign)

View → Q3

GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues

View → Q3

TODD STRATEGY GROUP for NOVARTIS, INC.

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View → 2A

PFIZER INC. for PFIZER INC.

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code

View → Q3

EMD SERONO, INC. for EMD SERONO INC

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Veterans, Defense, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → 3A

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate

Agriculture, Energy/Nuclear, Budget/Appropriations, Copyright/Patent/Trademark

View → 2A

MERCK & CO, INC. for MERCK & CO INC

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate

Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Animals

View →